Skip to main content

Site notifications

VAFSEO (Adjutor Healthcare Pty Ltd)

Product name
VAFSEO
Date registered
Evaluation commenced
Decision date
Approval time
244 (255 working days
Active ingredients
vadadustat
Registration type
NCE/NBE
Indication

Vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis.